Veracyte Inc To Acquire Decipher Biosciences Call Transcript
Good morning, ladies and gentlemen, and welcome to Veracyte's conference call regarding its agreement to acquire Decipher Biosciences. As a reminder, today's conference call is being recorded. I'd now like to hand the conference over to Tracy Morris, Veracyte's Vice President of Corporate Communications and Investor Relations. You may begin.
Thank you, Ashley. Good morning, everyone, and thanks for joining us today for a discussion of our agreement to acquire Decipher Biosciences, which we announced earlier this morning. We expect to close the acquisition by May 2021, subject to regulatory approval and the satisfaction of other customary conditions. In conjunction with today's announcement, Veracyte announced our preliminary financial results for the fourth quarter and full year ended December 31, 2020. This information may be found on our website. With me today are Bonnie Anderson, Veracyte's Chairman and Chief Executive Officer; Keith Kennedy, our Chief Operating Officer and Chief Financial
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |